Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
6 Tire Brands Reasonable for Seniors - 2Figure out How to Amplify Innovation and Infotainment Frameworks for Senior Drivers in SUVs
- 35 State of the art Advancements in Computer generated Simulation
- 4Explainer-Why are hepatitis B vaccines given to newborns?
- 5Huge solar flare no threat to Artemis 2 astronaut launch to the moon, NASA says
- Support Your Investment funds with These Individual accounting Thoughts
- 6 Popular Men's Aromas On the planet
- Asia's migrant workers debate if Gulf jobs are worth deadly risk of Iran war
- Figuring out the Business venture Code: The Response to Building an Effective Startup
- Change Your Skincare: 10 Inventive Magnificence Gadgets
- At least 18 Palestinians killed in latest clashes in Gaza
- The Best Portable Applications for Psychological wellness and Prosperity
- Catholic influencer shares death of 5-year-old son from 'severe' flu
- Overlooked infertility care should be part of national health services, says WHO
